摘要
目的探讨奥沙拉秦联合微生态制剂治疗溃疡性结肠炎的临床疗效。方法将2008年6月～2011年6月收治的92例溃疡性结肠炎患者随机分成两组,对照组46例单纯给予奥沙拉秦治疗,治疗组46例在对照组治疗的基础上加用微生态制剂,两组疗程均为4周。结果治疗组的总有效率为91.3%,对照组的总有效率为76.1%,两组相比较有显著性差异(P<0.05)。结论奥沙拉秦联合微生态制剂治疗溃疡性结肠炎疗效确切,不良反应较少,患者易于接受,值得临床推广应用。
Objective To explore the clinical effect of olsalazin and probiotic agents in treatment of ulcerative colitis. Methods 92 cases ulcerative colitis patients from June 2008 to June 2011 were randomly divided into two groups, 46 cases in the control group were received olsalazin, 46 cases in the treatment group were given olsalazin and probiotic agents for 4 weeks. Results After treatment, the total effective rate in the treatment group（91.3%） was significantly higher than that in the control group（76.1%） （P〈0.05）. Conclusion Olsalazin and probiotic agents are effective, less side-effect medicines and easily accepted by patients for treatment of ulcerative colitis, which is good for clinical application.
出处
《当代医学》
2012年第23期133-134,共2页
Contemporary Medicine
